Non-alcoholic fatty liver disease in underweight patients with ... - PLOS

2 downloads 0 Views 2MB Size Report
Nov 14, 2018 - Department of Radiology, Charité, Berlin, Germany. 4 [email protected] .... Euroscreen S.A., 101. Galmed Research and ...... tol. 2016; 65(6):1198–208. Epub 2016/06/18. https://doi.org/10.1016/j.jhep.2016.05.046 PMID:.
RESEARCH ARTICLE

Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study Lisa C. Adams ID*, Falk Lu¨bbe, Keno Bressem, Moritz Wagner, Bernd Hamm, Marcus R. Makowski Department of Radiology, Charite´, Berlin, Germany

a1111111111 a1111111111 a1111111111 a1111111111 a1111111111

OPEN ACCESS Citation: Adams LC, Lu¨bbe F, Bressem K, Wagner M, Hamm B, Makowski MR (2018) Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study. PLoS ONE 13(11): e0206450. https://doi.org/ 10.1371/journal.pone.0206450 Editor: Pavel Strnad, Medizinische Fakultat der RWTH Aachen, GERMANY Received: July 23, 2018 Accepted: October 13, 2018 Published: November 14, 2018 Copyright: © 2018 Adams et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability Statement: All relevant data are within the paper. Funding: MRM was funded by the Deutsche Forschungsgemeinschaft - SFB 1340/1 2018 and 5943/31/41. Funding was provided by BIH/Charite´ – Universita¨tsmedizin Berlin (DE) to LCA. BH has received research grants for the Department of Radiology, Charite´ – Universita¨tsmedizin Berlin from the following companies: 1. Abbott, 2. Actelion Pharmaceuticals, 3. Bayer Schering Pharma, 4. Bayer Vital, 5. BRACCO Group, 6.

* [email protected]

Abstract Non-alcoholic fatty liver disease (NAFLD) was shown to also occur in lean and underweight patients. So far, the prevalence of NAFLD in underweight individuals with and without inflammatory bowel disease (IBD) is insufficiently enlightened. In this cross-sectional age, gender and disease-matched case-control study, underweight patients (BMI0.05

0

14

0

5

p